Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer

被引:56
作者
Matsumoto, K
Yasugi, T
Nakagawa, S
Okubo, M
Hirata, R
Maeda, H
Yoshikawa, H
Taketani, Y
机构
[1] Univ Tokyo, Dept Obstet & Gynecol, Tokyo, Japan
[2] Saitama Med Sch, Saitama Med Ctr, Dept Transfus Med & Cell Therapy, Moroyama, Saitama, Japan
[3] Univ Tsukuba, Dept Obstet & Gynecol, Tsukuba, Ibaraki 305, Japan
关键词
human papillomavirus type 16; E6; variant; human leukocyte antigen;
D O I
10.1002/ijc.11332
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The enhanced oncogenicity of particular human papillomavirus type 16 (HPV16) E6 variants is population-dependent, implying the involvement of additional genetic cofactors. This study was designed to investigate the association between E6 variants and human leukocyte antigen (HLA) polymorphism within a Japanese population. Fifty-seven women with HPV16-positive cervical cancer were analyzed for E6 sequence variation and its relationship to HLA class 11 alleles. Compared with local controls (n = 138) and published controls (n = 916), DRB1*1501 and DQB1*0602 frequencies were significantly increased among patients with HPV16 E6 prototype (n = 11). Additionally, DRB1*1502 was positively associated with a particular E6 variant designated D25E (n = 25), although we could not find a significant association between HLA class 11 alleles and L83V variants (n = 16). Our observations suggest that a specific match between E6 variant proteins and HLA types may contribute to HPV16-related cervical carcinogenesis. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:919 / 922
页数:4
相关论文
共 24 条
[1]   Adjusting for multiple testing when reporting research results: The Bonferroni vs Holm methods [J].
Aickin, M ;
Gensler, H .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (05) :726-728
[2]   Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions [J].
Andersson, S ;
Alemi, M ;
Rylander, E ;
Strand, A ;
Larsson, B ;
Sallström, J ;
Wilander, E .
BRITISH JOURNAL OF CANCER, 2000, 83 (03) :307-310
[3]   HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY [J].
APPLE, RJ ;
ERLICH, HA ;
KLITZ, W ;
MANOS, MM ;
BECKER, TM ;
WHEELER, CM .
NATURE GENETICS, 1994, 6 (02) :157-162
[4]   Asian-American variants of human papillomavirus 16 and risk for cervical cancer:: a case-control study [J].
Berumen, J ;
Ordoñez, RM ;
Lazcano, E ;
Salmeron, J ;
Galvan, SC ;
Estrada, RA ;
Yunes, E ;
Garcia-Carranca, A ;
Madrigal-de la Campa, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (17) :1325-1330
[5]   HLA class II alleles associated with infection by HPV16 in cervical cancer in situ [J].
Beskow, AH ;
Josefsson, AM ;
Gyllensten, UB .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (06) :817-822
[6]  
Bontkes HJ, 1998, INT J CANCER, V78, P166, DOI 10.1002/(SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO
[7]  
2-X
[8]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[9]   Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women [J].
Cuzick J. ;
Terry G. ;
Ho L. ;
Monaghan J. ;
Lopes A. ;
Clarkson P. ;
Duncan I. .
British Journal of Cancer, 2000, 82 (7) :1348-1352
[10]   THE ASSOCIATION OF AN HPV16 ONCOGENE VARIANT WITH HLA-B7 HAS IMPLICATIONS FOR VACCINE DESIGN IN CERVICAL-CANCER [J].
ELLIS, JRM ;
KEATING, PJ ;
BAIRD, J ;
HOUNSELL, EF ;
RENOUF, DV ;
ROWE, M ;
HOPKINS, D ;
DUGGANKEEN, MF ;
BARTHOLOMEW, JS ;
YOUNG, LS ;
STERN, PL .
NATURE MEDICINE, 1995, 1 (05) :464-470